{"id":15039,"date":"2013-07-15T11:02:39","date_gmt":"2013-07-15T15:02:39","guid":{"rendered":"http:\/\/therapytoronto.ca\/news\/?p=15039"},"modified":"2013-07-28T13:13:03","modified_gmt":"2013-07-28T17:13:03","slug":"sudden-decline-in-testosterone-may-cause-parkinsons-disease-symptoms-in-men","status":"publish","type":"post","link":"https:\/\/therapytoronto.ca\/news\/2013\/07\/sudden-decline-in-testosterone-may-cause-parkinsons-disease-symptoms-in-men\/","title":{"rendered":"Sudden Decline in Testosterone May Cause Parkinson&#8217;s Disease Symptoms in Men"},"content":{"rendered":"<p>From the Rush University Medical Center media release:<\/p>\n<p style=\"padding-left: 30px;\"><a href=\"http:\/\/therapytoronto.ca\/news\/wp-content\/uploads\/2013\/07\/walker-parkinsons.jpg\"><img loading=\"lazy\" class=\"alignright size-full wp-image-14995\" alt=\"walker parkinsons\" src=\"http:\/\/therapytoronto.ca\/news\/wp-content\/uploads\/2013\/07\/walker-parkinsons.jpg\" width=\"193\" height=\"290\" \/><\/a>The results of a new study by neurological researchers at Rush University Medical Center show that <strong>a sudden decrease of testosterone, the male sex hormone, may cause Parkinson&#8217;s like symptoms in male mice<\/strong>. The findings were recently published in the\u00a0<em>Journal of Biological Chemistry<\/em>.<\/p>\n<p style=\"padding-left: 30px;\">One of the major roadblocks for discovering drugs against Parkinson&#8217;s disease is the unavailability of a reliable animal model for this disease.<\/p>\n<p style=\"padding-left: 30px;\">&#8220;While scientists use different toxins and a number of complex genetic approaches to model Parkinson&#8217;s disease in mice, <strong>we have found that the sudden drop in the levels of testosterone following castration is sufficient to cause persistent Parkinson&#8217;s like pathology and symptoms in male mice<\/strong>,&#8221; said Dr. Kalipada Pahan, lead author of the study and the Floyd A. Davis endowed professor of neurology at Rush. &#8220;We found that the supplementation of testosterone in the form of 5-alpha dihydrotestosterone (DHT) pellets reverses Parkinson&#8217;s pathology in male mice.&#8221;<\/p>\n<p style=\"padding-left: 30px;\">&#8220;In men, testosterone levels are intimately coupled to many disease processes,&#8221; said Pahan. Typically, in healthy males, testosterone level is the maximum in the mid-30s, which then drop about one percent each year. However, <strong>testosterone levels may dip drastically due to stress or sudden turn of other life events, which may make somebody more vulnerable to Parkinson&#8217;s disease<\/strong>.<\/p>\n<p style=\"padding-left: 30px;\">&#8220;Therefore, preservation of testosterone in males may be an important step to become resistant to Parkinson&#8217;s disease,&#8221; said Pahan.<\/p>\n<p style=\"padding-left: 30px;\"><strong>Understanding how the disease works is important to developing effective drugs that protect the brain and stop the progression of Parkinson&#8217;s disease.<\/strong> Nitric oxide is an important molecule for our brain and the body.<\/p>\n<p style=\"padding-left: 30px;\">&#8220;However, when nitric oxide is produced within the brain in excess by a protein called inducible nitric oxide synthase, neurons start dying,&#8221; said Pahan.<\/p>\n<p style=\"padding-left: 30px;\">&#8220;This study has become more fascinating than we thought,&#8221; said Pahan. &#8220;After castration, levels of inducible nitric oxide synthase (iNOS) and nitric oxide go up in the brain dramatically. <strong>Interestingly, castration does not cause Parkinson&#8217;s like symptoms in male mice deficient in iNOS gene, indicating that loss of testosterone causes symptoms via increased nitric oxide production<\/strong>.&#8221;<\/p>\n<p style=\"padding-left: 30px;\">&#8220;Further research must be conducted to see how we could potentially target testosterone levels in human males in order to find a viable treatment,&#8221; said Pahan.<\/p>\n<p>Other researchers at Rush involved in this study were Saurabh Khasnavis, PhD, student, Anamitra Ghosh, PhD, student, and Avik Roy, PhD, research assistant professor.<\/p>\n<p>This research was supported by a grant from the National Institutes of Health that received the highest score for its scientific merit in the particular cycle it was reviewed.<\/p>\n<p>Parkinson&#8217;s is a slowly progressive disease that affects a small area of cells within the mid-brain known as the substantia nigra. Gradual degeneration of these cells causes a reduction in a vital chemical neurotransmitter, dopamine. The decrease in dopamine results in one or more of the classic signs of Parkinson&#8217;s disease that includes resting tremor on one side of the body; generalized slowness of movement; stiffness of limbs and gait or balance problems. The cause of the disease is unknown. Both environmental and genetic causes of the disease have been postulated.<\/p>\n<p>Parkinson&#8217;s disease affects about 1.2 million patients in the United States and Canada. Although 15 percent of patients are diagnosed before age 50, it is generally considered a disease that targets older adults, affecting one of every 100 persons over the age of 60. This disease appears to be slightly more common in men than women.<\/p>\n<!-- AddThis Advanced Settings generic via filter on the_content --><!-- AddThis Share Buttons generic via filter on the_content -->","protected":false},"excerpt":{"rendered":"<p>From the Rush University Medical Center media release: The results of a new study by neurological researchers at Rush University Medical Center show that a sudden decrease of testosterone, the&#8230; <a class=\"read-more-link\" href=\"https:\/\/therapytoronto.ca\/news\/2013\/07\/sudden-decline-in-testosterone-may-cause-parkinsons-disease-symptoms-in-men\/\">Read more &raquo;<\/a><!-- AddThis Advanced Settings generic via filter on get_the_excerpt --><!-- AddThis Share Buttons generic via filter on get_the_excerpt --><\/p>\n","protected":false},"author":5,"featured_media":0,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":[],"categories":[321,10,6],"tags":[],"_links":{"self":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/15039"}],"collection":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/users\/5"}],"replies":[{"embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/comments?post=15039"}],"version-history":[{"count":3,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/15039\/revisions"}],"predecessor-version":[{"id":15041,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/posts\/15039\/revisions\/15041"}],"wp:attachment":[{"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/media?parent=15039"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/categories?post=15039"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/therapytoronto.ca\/news\/wp-json\/wp\/v2\/tags?post=15039"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}